TY  - JOUR 
AU  - Skrede, S
AU  - Jesús Martíns, Luis Ricardo
AU  - Berge, RK
AU  - Steen, VM
AU  - González López, Miguel
AU  - Ferno, J
PY  - 2014
SN  - 1461-1457
UR  - http://hdl.handle.net/20.500.11940/6245
AB  - Rats are used as animal models in the study of antipsychotic-induced metabolic adverse effects, with oral drug administration yielding hyperphagia, weight gain and, in some cases, lipogenic effects. However, the rapid half-life of these drugs in rats,...
LA  - eng
KW  - AMP-Activated Protein Kinases
KW  - Adipose Tissue
KW  - Animals
KW  - Antipsychotic Agents
KW  - Arcuate Nucleus of Hypothalamus
KW  - Benzodiazepines
KW  - Delayed-Action Preparations
KW  - Disease Models, Animal
KW  - Eating
KW  - Female
KW  - Gene Expression
KW  - Gene Knockdown Techniques
KW  - Liver
KW  - Metabolic Diseases
KW  - Olanzapine
KW  - Rats
KW  - Triglycerides
KW  - Ventromedial Hypothalamic Nucleus
KW  - Weight Gain
TI  - Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects
DO  - 10.1017/S1461145713000862
T2  - INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
M2  - 91
VL  - 17
ER  -